R Zittoun
About
R Zittoun is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, R Zittoun has authored 231 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Hematology, 74 papers in Oncology and 57 papers in Public Health, Environmental and Occupational Health. Recurrent topics in R Zittoun's work include Acute Myeloid Leukemia Research (82 papers), Acute Lymphoblastic Leukemia research (48 papers) and Chronic Lymphocytic Leukemia Research (32 papers). R Zittoun is often cited by papers focused on Acute Myeloid Leukemia Research (82 papers), Acute Lymphoblastic Leukemia research (48 papers) and Chronic Lymphocytic Leukemia Research (32 papers). R Zittoun collaborates with scholars based in France, Netherlands and Belgium. R Zittoun's co-authors include JP Marie, J. P. Marie, Stefan Suciu, Jean‐Pierre Marie, Ollivier Legrand, Alain Delmer, G. Solbu, Ghislaine Simonin, Bob Löwenberg and Jean‐Yves Perrot and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.
In The Last Decade
R Zittoun
225 papers receiving 6.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| R Zittoun France | 45 | 3.1k | 2.5k | 2.0k | 1.9k | 1.3k | 231 | 6.8k | ||
| E. Thiel Germany | 46 | 2.1k 0.7× | 1.7k 0.7× | 1.4k 0.7× | 1.7k 0.9× | 1.4k 1.0× | 208 | 6.9k | ||
| Enric Carreras Spain | 52 | 5.1k 1.6× | 2.2k 0.9× | 848 0.4× | 1.2k 0.6× | 1.4k 1.1× | 255 | 8.4k | ||
| Giuseppe Masera Italy | 45 | 3.0k 1.0× | 844 0.3× | 1.0k 0.5× | 3.9k 2.1× | 1.3k 1.0× | 239 | 7.2k | ||
| Christina Peters Austria | 48 | 4.1k 1.3× | 2.1k 0.8× | 948 0.5× | 2.2k 1.1× | 1.1k 0.8× | 242 | 8.2k | ||
| Bassem I. Razzouk United States | 43 | 2.8k 0.9× | 1.3k 0.5× | 977 0.5× | 2.9k 1.5× | 524 0.4× | 105 | 5.4k | ||
| Bruce M. Camitta United States | 60 | 6.8k 2.2× | 2.4k 1.0× | 1.8k 0.9× | 6.9k 3.7× | 1.4k 1.1× | 215 | 12.5k | ||
| Guy Leverger France | 45 | 2.7k 0.9× | 1.1k 0.4× | 1.2k 0.6× | 1.9k 1.0× | 805 0.6× | 242 | 6.0k | ||
| Karen K. Ballen United States | 45 | 5.8k 1.8× | 2.1k 0.8× | 1.0k 0.5× | 1.8k 0.9× | 1.9k 1.5× | 234 | 8.1k | ||
| CR Pinkerton United Kingdom | 38 | 751 0.2× | 1.5k 0.6× | 999 0.5× | 1.1k 0.6× | 468 0.4× | 157 | 5.2k | ||
| André Baruchel France | 55 | 4.3k 1.4× | 1.6k 0.6× | 3.0k 1.5× | 4.3k 2.3× | 1.3k 1.0× | 333 | 9.7k |
Countries citing papers authored by R Zittoun
Since
Specialization
Citations
This map shows the geographic impact of R Zittoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Zittoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Zittoun more than expected).
Fields of papers citing papers by R Zittoun
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by R Zittoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Zittoun. The network helps show where R Zittoun may publish in the future.
Co-authorship network of co-authors of R Zittoun
This figure shows the co-authorship network connecting the top 25 collaborators of R Zittoun. A scholar is included among the top collaborators of R Zittoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Zittoun. R Zittoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Witte, T. de, R Zittoun, L Resegotti, et al.. (2000). The type of anthracycline administered during remission induction and consolidation therapy of AML has an impact on feasibility of subsequent autologous or allogeneic transplantation and induced marrow toxicity: preliminary results of the EORTC-Gimema AML-10 randomized trial.. Blood. 96(11).
2.
Legrand, Ollivier, R Zittoun, & J. P. Marie. (1999). Role of MRP1 in multidrug resistance in acute myeloid leukemia. Leukemia. 13(4). 578–584.
3.
Watson, Maggie, Keith Wheatley, G Harrison, et al.. (1999). Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone. Cancer. 86(7). 1231–1239.
4.
Legrand, Ollivier, Ghislaine Simonin, Jean‐Yves Perrot, R Zittoun, & Jean-Pierre Marie. (1999). Both Pgp and MRP1 Activities Using Calcein-AM Contribute to Drug Resistance in AML. Advances in experimental medicine and biology. 457. 161–175.
5.
Löwenberg, Bob, Stefan Suciu, E Archimbaud, et al.. (1998). Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.. Journal of Clinical Oncology. 16(3). 872–881.
6.
Legrand, Ollivier, Ghislaine Simonin, Jean‐Yves Perrot, R Zittoun, & Jean‐Pierre Marie. (1998). Pgp and MRP Activities Using Calcein-AM Are Prognostic Factors in Adult Acute Myeloid Leukemia Patients. Blood. 91(12). 4480–4488.
7.
Legrand, Ollivier, Jean‐Yves Perrot, Ruoping Tang, et al.. (1996). Expression of the multidrug resistance‐associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. British Journal of Haematology. 94(1). 23–33.
8.
Zhou, Da-Cheng, et al.. (1996). Sequential emergence ofMRP- andMDR1-gene over-expression as well asMDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines. International Journal of Cancer. 65(3). 365–371.
9.
Sonneveld, Pieter, J. P. Marie, C. Huisman, et al.. (1996). Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.. PubMed. 10(11). 1741–50.
10.
Zittoun, R, Stefan Suciu, G. Solbu, et al.. (1995). Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study. Blood. 86(10). 1718–1718.
11.
Zhou, Daoping, R Zittoun, & J. P. Marie. (1995). Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia.. PubMed. 9(10). 1661–6.
12.
Russo, Domenico, J. P. Marie, D-C Zhou, et al.. (1994). Evaluation of the Clinical Relevance of the Anionic Glutathione-S-Transferase (GSTπ) and Multidrug Resistance (mdr-1) Gene Coexpression in Leukemias and Lymphomas. Leukemia & lymphoma. 15(5-6). 453–468.
13.
Legrand, O., et al.. (1993). CEFTAZIDIME : AVANTAGES DES PERFUSIONS CONTINUES CHEZ UN MALADE EN APLASIE. La Presse Médicale. 22(16). 786–786.
14.
Zittoun, R, et al.. (1988). Implications psychologiques des cancers : conséquences des traitements et modalités d'adaptation.. Bulletin du Cancer.
15.
ROBÈRT, K.‐H., J. Einhorn, B. Kornhuber, Michael Peckham, & R Zittoun. (1988). European Undergraduate Education in Oncology: A report of the EORTC Education Branch. Acta Oncologica. 27(4). 423–425.
16.
Rambaud, Jean–Claude, A Galian, Guy Touchard, et al.. (1986). Digestive Tract and Renal Small Vessel Hyalinosis, Idiopathic Nonarteriosclerotic Intracerebral Calcifications, Retinal Ischemic Syndrome, and Phenotypic Abnormalities. Gastroenterology. 90(4). 930–938.
17.
Audouin, J, et al.. (1986). [Cryptosporidiosis in grafting of allogeneic bone marrow].. PubMed. 15(30). 1414–6.
18.
Jehn, U., R Zittoun, & Bob Löwenberg. (1985). AML-6- und AML-7-Studie zur Behandlung der akuten myeloischen Leukämie. Oncology Research and Treatment. 8(3). 160–164.
19.
Zittoun, R, et al.. (1978). Manifestations et complications hématologiques du syndrome de Sjögren.. 54.
20.
Dao, C. N., et al.. (1978). Maladie de Hodgkin: valeur des critères dits de pronostic et de l'association radio-chimiothérapique dans les stabes lymphoïdes localisés (I et II). 94 malades laparotomisés.. La Nouvelle presse médicale. 7(10).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by E. Thiel Breakdown of academic impact, for papers by Enric Carreras Breakdown of academic impact, for papers by Giuseppe Masera Breakdown of academic impact, for papers by Christina Peters Breakdown of academic impact, for papers by Bassem I. Razzouk Breakdown of academic impact, for papers by Bruce M. Camitta Breakdown of academic impact, for papers by Guy Leverger Breakdown of academic impact, for papers by Karen K. Ballen Breakdown of academic impact, for papers by CR Pinkerton Breakdown of academic impact, for papers by André Baruchel